153 related articles for article (PubMed ID: 19333880)
1. The role of a murine transplantation model of atherosclerosis regression in drug discovery.
Feig JE; Quick JS; Fisher EA
Curr Opin Investig Drugs; 2009 Mar; 10(3):232-8. PubMed ID: 19333880
[TBL] [Abstract][Full Text] [Related]
2. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.
Trogan E; Feig JE; Dogan S; Rothblat GH; Angeli V; Tacke F; Randolph GJ; Fisher EA
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3781-6. PubMed ID: 16537455
[TBL] [Abstract][Full Text] [Related]
3. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.
Feig JE; Rong JX; Shamir R; Sanson M; Vengrenyuk Y; Liu J; Rayner K; Moore K; Garabedian M; Fisher EA
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7166-71. PubMed ID: 21482781
[TBL] [Abstract][Full Text] [Related]
4. Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages.
Feig JE; Shang Y; Rotllan N; Vengrenyuk Y; Wu C; Shamir R; Torra IP; Fernandez-Hernando C; Fisher EA; Garabedian MJ
PLoS One; 2011; 6(12):e28534. PubMed ID: 22163030
[TBL] [Abstract][Full Text] [Related]
5. Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions.
Feig JE; Fisher EA
Methods Mol Biol; 2013; 1027():123-35. PubMed ID: 23912984
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE.
Hou M; Xia M; Zhu H; Wang Q; Li Y; Xiao Y; Zhao T; Tang Z; Ma J; Ling W
Cell Biochem Funct; 2007; 25(1):33-44. PubMed ID: 16981222
[TBL] [Abstract][Full Text] [Related]
7. Regression of atherosclerosis: insights from animal and clinical studies.
Feig JE
Ann Glob Health; 2014; 80(1):13-23. PubMed ID: 24751561
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
9. Effects of FXR in foam-cell formation and atherosclerosis development.
Guo GL; Santamarina-Fojo S; Akiyama TE; Amar MJ; Paigen BJ; Brewer B; Gonzalez FJ
Biochim Biophys Acta; 2006 Dec; 1761(12):1401-9. PubMed ID: 17110163
[TBL] [Abstract][Full Text] [Related]
10. The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis.
Jawien J
Curr Pharm Biotechnol; 2012 Oct; 13(13):2435-9. PubMed ID: 22280417
[TBL] [Abstract][Full Text] [Related]
11. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.
Feig JE; Pineda-Torra I; Sanson M; Bradley MN; Vengrenyuk Y; Bogunovic D; Gautier EL; Rubinstein D; Hong C; Liu J; Wu C; van Rooijen N; Bhardwaj N; Garabedian M; Tontonoz P; Fisher EA
J Clin Invest; 2010 Dec; 120(12):4415-24. PubMed ID: 21041949
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
13. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha.
Lu KY; Ching LC; Su KH; Yu YB; Kou YR; Hsiao SH; Huang YC; Chen CY; Cheng LC; Pan CC; Lee TS
Circulation; 2010 Apr; 121(16):1828-37. PubMed ID: 20385932
[TBL] [Abstract][Full Text] [Related]
15. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
16. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
17. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution.
van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M
Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.
Hoekstra M; Nahon JE; de Jong LM; Kröner MJ; de Leeuw LR; Van Eck M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1402-1409. PubMed ID: 30776415
[TBL] [Abstract][Full Text] [Related]
19. The liver X receptor and atherosclerosis.
Scott J
N Engl J Med; 2007 Nov; 357(21):2195-7. PubMed ID: 18032771
[No Abstract] [Full Text] [Related]
20. Antiatherosclerotic effect of farnesoid X receptor.
Mencarelli A; Renga B; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
